| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cellectar Biosciences, Inc. (CLRB) has 4 insiders with recent SEC Form 4 filings, including 8 buys and 3 sells. CLRB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 12.8K | $39.6K | - | |
| CEO | 11.6K | $36.1K | - | |
| CFO | 6.4K | $19.9K | - | |
| Dir | 10 | $31.00 | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2020 | Elefant Dov | Chief Financial Officer | Buy | 7,407 | $1.35 | $9,999.45 | +170.4% | |
| Jun 5, 2020 | Elefant Dov | Chief Financial Officer | Buy | 4,348 | $1.15 | $4,978.46 | New | |
| Jun 5, 2020 | Longcor Jarrod | Chief Business Officer | Buy | 65,218 | $1.15 | $74,674.61 | +893.4% | |
| Jun 5, 2020 | Caruso James V | President And CEO | Buy | 21,740 | $1.15 | $24,892.30 | +96.5% | |
| Jun 4, 2020 | Hill Stephen A | Director | Buy | 18,000 | $1.08 | $19,438.20 | New | |
| Feb 28, 2019 | Longcor Jarrod | Chief Business Officer | Buy | 100 | $2.00 | $200.25 | +1.4% | |
| Nov 30, 2018 | Caruso James V | President And CEO | Buy | 1,000 | $2.28 | $2,282.00 | +4.7% | |
| Nov 29, 2018 | Hill Stephen A | Director | Sell | 992 | $2.21 | $2,192.41 | -94.9% | |
| Aug 16, 2018 | Longcor Jarrod | Chief Business Officer | Buy | 500 | $2.71 | $1,355.00 | +7.5% | |
| Mar 13, 2018 | Longcor Jarrod | Chief Business Officer | Sell | 13,000 | $1.18 | $15,397.20 | -16.3% |